Scientists from Duke-NUS Medical School (Duke-NUS) at Singapore have developed a new approach using the Zika virus to de...
Taiwan-based BioGate Precision Medicine Corp., a member of Powerchip Group, has unveiled an innovative breakthrough in p...
Epsilogen, a leading immunoglobulin E (IgE) antibodies developer treating cancer, and global biopharma leader Lonza have...
In a breakthrough for personalised oncology, scientists from the National University of Singapore (NUS) and the National...
A collaborative research team from the Department of Chemical Engineering and the School of Convergence Science and Tech...
Could you give us an overview of the GHIT Fund's mission and how it originated? The idea for the GHIT (Global Health In...
Orthohantaviruses, highly transmissible zoonotic pathogens, are notorious for causing haemorrhagic fever with renal synd...
As the world marks Cancer Awareness Month, Malaysia has made significant strides in the field of cancer treatment, earni...
Daiichi Sankyo, an innovative global healthcare company, has launched its subsidiary Daiichi Sankyo Singapore ...
China's AffaMed Therapeutics, has obtained New Drug Application (NDA) from Singapore Health Sciences Authority (HSA...
The Australian government is providing $50 million to develop and commercialise the world’s most advanced artifici...
Japan headquartered Astellas Pharma and US-based biotech startup Kelonia Therapeutics have announced a collaborative eff...
A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...
According to the World Health Organization (WHO), approximately 2.5 billion people worldwide are estimated to have some ...
The University of Texas MD Anderson Cancer Center in the US, and South Korea-based startup C-Biomex have announced ...
Recce Pharmaceuticals Limited, the Company developing a New Class of Synthetic Anti-Infectives, has signed Memorand...
Imagine a world where a non-invasive breast cancer test delivers results within 15 minutes, costing less than half the p...
Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...
Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...
The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...
The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...
The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...
